NCT02131467View on ClinicalTrials.gov

Safety and Tolerability of Perampanel in Cervical Dystonia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Cervical Dystonia
Interventions
DRUG

Perampanel

oral drug

Trial Locations (5)

10003

Beth Israel Medical Center, New York

30322

Emory University School of Medicine, Atlanta

44195

Cleveland Clinic, Cleveland

60612

Rush University Medical Center, Chicago

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
collaborator

Dystonia Study Group

OTHER

lead

University Health Network, Toronto

OTHER

NCT02131467 - Safety and Tolerability of Perampanel in Cervical Dystonia | Biotech Hunter | Biotech Hunter